| |
|
|
|
Vaccinex Inc.  
|
|
5 0 (0%) |
11-15 16:00 |
|
Open: |
5 |
Pre close: |
5 |
Target:
|
6.69
|
|
High: |
5.38 |
Low: |
4.81 |
Resistance:
|
5.73
6.45
|
|
Volume: |
1,197 |
Market Cap: |
74M |
Support:
|
4.56
3.79
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.91
 |
MACD |
MACD(12,26):
|
-0.30  |
|
MA(20): |
5.32 |
Signal(12,26,9): |
-0.28 |
|
MA(100): |
5.48 |
Stochastic Oscillator |
%K(14,3):
|
11.11 |
|
MA(250): |
5.43 |
%D(3): |
16.11 |
|
Average Volume(K) |
3-Month: |
512
|
52-Week |
High:
|
8.49 |
|
10-Days: |
233 |
Low: |
3.32 |
|
RSI |
RSI(14):
|
45.15 |
Change(%): |
-21.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-3.010 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
14.86 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-348.6 |
Shares Float (M) |
3.05 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
84.78 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-80.2 |
% Held by Institutions |
2.14 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
-0.021 |
Shares Short (K) |
19 |
|
Book Value (p.s.) |
-2.300 |
EBITDA (p.s.) |
-2.206 |
P/E |
-1.66 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-2.17 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-29.20 |
P/S |
100.00 |
|
Operating Margin |
-6460.47 |
Levered Free Cash Flow
(M) |
-18.58 |
P/CF |
-2.54 |
|
|
|
|
|
|
